Aclaris Therapeutics (ACRS) Return on Sales (2017 - 2026)
Aclaris Therapeutics (ACRS) posted quarterly Return on Sales of 0.19% for Q1 2026, down 6.0% year-over-year from 0.2% in Q1 2025, and up 22.39% quarter-over-quarter from 0.24% in Q4 2025.
Aclaris Therapeutics (ACRS) Return on Sales (2017 - 2026) Analysis & Trends
Aclaris Therapeutics' Return on Sales history runs 10 years deep, the most recent figure standing at 0.19% for Q1 2026.
- In Q1 2026, Return on Sales fell 6.0% year-over-year to 0.19%; the TTM figure through Mar 2026 stood at 0.13% (down 4.0% YoY), while the FY2025 annual figure was 0.35%, down 28.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.19%, up from 0.24% in the prior quarter.
- The five-year high for Return on Sales was 0.02% in Q3 2022, with the low at 0.26% in Q1 2022.
- The 5-year median for Return on Sales is 0.11% (2023), against an average of 0.12%.
- The sharpest annual moves came in 2022 and 2025: Return on Sales rose 21 bps in 2022, then decreased 12 bps in 2025.
- Aclaris Therapeutics' Return on Sales stood at 0.06% in 2022, then sank by 98 bps to 0.11% in 2023, then dropped by 5 bps to 0.12% in 2024, then slumped by 106 bps to 0.24% in 2025, then climbed by 22 bps to 0.19% in 2026.
- Business Quant data shows ACRS's Return on Sales at 0.19% in Q1 2026, 0.24% in Q4 2025, and 0.06% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Aclaris Therapeutics | 808.18 Mn | 716.63 Mn | 1.41 Mn | -0.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.34% |
| Mar 31, 2026 | -0.19% |
| Dec 31, 2025 | -0.24% |
| Sep 30, 2025 | -0.06% |
| Jun 30, 2025 | -0.11% |
| Mar 31, 2025 | -0.13% |
| Dec 31, 2024 | -0.12% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.04% |
| Mar 31, 2024 | -0.07% |
| Dec 31, 2023 | -0.11% |
| Sep 30, 2023 | -0.04% |
| Jun 30, 2023 | -0.21% |
| Mar 31, 2023 | -0.13% |
| Dec 31, 2022 | -0.06% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.21% |
| Mar 31, 2022 | -0.26% |
| Dec 31, 2021 | -0.25% |
| Sep 30, 2021 | -0.23% |